AS
Aston Sci is a clinical-stage biopharmaceutical company developing therapeutic cancer vaccines targeting oncology, immunology, and geriatrics to address cancer recurrence and treatment-related side effects. Their focus on efficient clinical development aims to improve patient outcomes in the fight against cancer.
Updated 4 months ago
Funding
$22.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Aston Sci is a clinical-stage biopharmaceutical company developing therapeutic cancer vaccines targeting oncology, immunology, and geriatrics to address cancer recurrence and treatment-related side effects. Their focus on efficient clinical development aims to improve patient outcomes in the fight against cancer.